Avoid doubling up on injections to make up for a missed dose
The products also may have a sub-potent ethanol content, which leads to a lack of efficacy
After resolving a clinical hold installed by the FDA for manufacturing reasons, the companys CEO said it will take time to re-establish its efforts with the agency
Kobori T, Onishi Y, Yoshida Y, Tahara T, Kikuchi T, Kubota T, et al
Picard K, Griffiths M, Mager DR, Richard C
Beginning July 1, 2026, the Centers for Medicare & Medicaid Services (CMS) will launch the Medicare GLP-1 Bridge Program, a temporary demonstration designed to provide eligible Medicare Part D beneficiaries with access to certain GLP-1 medications through December 31, 2027